Catheter-related infections in chronic hemodialysis: A clinical and economic perspective

International Urology and Nephrology

Volumn 45, Issue 3, 2013, Pages 817-823

  Ştefan, Gabriel ^a   Stancu, Simona ^a   Căpuşă, Cristina ^a   Ailioaie, Oana Ramaiana ^a   Mircescu, Gabriel ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Bridge angioaccess; Catheter related bacteremia; Healthcare costs; Hemodialysis; Metastatic infectious complications

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANEMIA; ARTICLE; BACTEREMIA; CATHETER INFECTION; DIABETIC NEPHROPATHY; DIALYSIS CATHETER; ENTEROCOCCUS FAECIUM; FEMALE; GLOMERULONEPHRITIS; HEALTH CARE COST; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; METASTASIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; RENOVASCULAR DISEASE; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; VASCULAR ACCESS;

EID: 84879471490     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0244-7     Document Type: Article

References (30)

1. Bloembergen WE, Port FK (1996) Epidemiological perspective on infections in chronic dialysis patients. Adv Ren Replace Ther 3:201-207
2. Nassar GM, Ayus J (2001) Infectious complications of the hemodialysis access. Kydney Int 60:1-13
3. Katneni R, Hedayati S (2007) Central venous catheter-related bacteremia in chronic hemodialysis patients: epidemiology and evidence-based management. Nat Clin Pract Nephrol 3(5):256-266
4. Taylor G, Gravel D, Johnston L (2004) Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control 32:155-160
5. Vandecasteele SJ, Boelaert JR, De Vriese AS (2009) Staphylococcus aureus infection in hemodialysis: what a nephrologist should know. Clin J Am Soc Nephrol 4:1388-1400
6. Lemaire X, Morena M, Leary-Moragues H et al (2009) Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis. Blood Purif 28:21-28
7. Allon M (2004) Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 44:779-791
8. Teehan GS, Ruthazer R, Balakrishnan VS, Snydman D, Jaber BL (2004) Iron storage indices and risk of bacterial infections in hemodialysis patients. Hemodial Int 8:226-232
9. Ramanathan V, Chiu EJ, Thomas JT et al (2007) Healthcare costs associated with hemodialysis catheter related infections: a single center experience. Infect Control Hosp Epidemiol 28:606-609
10. Nissenson AR, Dylan ML, Griffiths RI et al (2005) Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis. Am J Kidney Dis 46:301-308
11. Engemann JJ, Friedman JY, Reed SD et al (2005) Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 26:534-539
12. Danese MD, Griffiths R, Dylan M, Yu HT, Dubois R, Nissenson R (2006) Mortality differences among organisms causing septicemia in hemodialysis patients. Hemodial Int 10:56-62
13. Al-Solaiman Y, Estrada E, Allon M (2011) The spectrum of infections in catheter-dependent hemodialysis patients. Clin J Am Soc Nephrol 6:2247-2252
14. Poole CV, Carlton D, Bimbo L, Allon M (2004) Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant 19:1237-1244
15. Johnson LB, Jose J, Yousif F, Pawlak J, Saravolatz LD (2009) Prevalence of colonization with community-associated methicillin-resistant Staphylococcus aureus among end-stage renal disease patients and healthcare workers. Infect Control Hosp Epidemiol 30:4-8
16. Lederer SR, Riedelsdorf G, Schiffl H (2007) Nasal carriage of methicillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among out clinic haemodialysis patients. Eur J Med Res 12:284-288
17. Inrig JK, Reed S, Szczech LA et al (2006) Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. Clin J Am Soc Nephrol 1(3):518-524
18. Marr KA, Kong L, Fowler VG et al (1998) Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int 54:1694-1699
19. Marr KA (2000) Staphylococcus aureus bacteremia in patients undergoing hemodialysis. Semin Dial 13:23-29
20. Zimmerli W, Lew PD, Waldvogel FA (1984) Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest 73:1191-1200
21. Parienti JJ, Thirion M, Mégarbane B et al (2008) Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 28:2413-2422
22. Tanriover B, Carlton D, Saddekni S et al (2000) Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int 57:2151-2155
23. Unver S, Atasoyu E, Evrenkaya TR, Ardic N, Ozyurt M (2006) Risk factors for the infections caused by temporary double-lumen hemodialysis catheters. Arch Med Res 37:348-352
24. Sanavi S, Ghods A, Afshar R (2007) Catheter associated infections in hemodialysis patients. Saudi J Kidney Dis Transpl 18:43-46
25. Goldstein SL, Ikizler TA, Zappitelli M, Silverstein DM, Ayus JC (2009) Non-infected hemodialysis catheters are associated with increased inflammation compared to arteriovenous fistulas. Kidney Int 76:1063-1069
26. Cappelli G, Tetta C, Canaud B (2005) Is biofilm a cause of silent chronic inflammation in haemodialysis patients? A fascinating working hypothesis. Nephrol Dial Transplant 20:266-270
27. Sherertz RJ, Carruth WA, Marosok RD, Espeland MA, Johnson RA, Solomon DD (1995) Contribution of vascular catheter material to the pathogenesis of infection: the enhanced risk of silicone in vivo. J Biomed Mater Res 29:635-645
28. Marosok R, Washburn R, Indorf A, Solomon D, Sheretz R (1996) Contribution of vascular catheter material to the pathogenesis of infection: depletion of complement by silicone elastomer in vitro. J Biomed Mater Res 30:245-250
29. Lee H, Manns B, Taub K et al (2002) Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 40:611-622
30. Manns B, Tonelli M, Yilmaz S et al (2005) Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol 16:201-209